CD8A and neoplasm: In murine melanoma and pancreatic cancer models, microbial SCFAs and butyrate through HDAC inhibition, enhance the anti-tumor activity of CD8+ cytotoxic T lymphocytes leading to increased effector cytokine production and proliferation (51).